SEC Sues Swiss Man Over Illicit Trading In GSK Deal
The U.S. Securities and Exchange Commission has filed a complaint against a Swiss national, alleging that he schemed to trade on insider knowledge of GlaxoSkithKline PLC's $566 million takeover of Minnesota-based...To view the full article, register now.
Already a subscriber? Click here to view full article